Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Der Urologe. Ausg. A
|
July 25, 2008
[CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
P J Bastian, J Ellinger, A von Rücker, et al.
The Journal of Investigative Dermatology
|
July 1, 1983
Keratin classes: molecular markers for different types of epithelial differentiation
T T Sun, R Eichner, W G Nelson, et al.
The Prostate
|
September 11, 2001
GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue
J K Parsons, C P Nelson, W R Gage, et al.
Andrology
|
October 2, 2014
Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men
W Wulaningsih, M Van Hemelrijck, K Michaelsson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1997
Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation
T L DeWeese, J C Walsh, L E Dillehay, et al.
Journal of the National Cancer Institute
|
February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancer
M G Sanda, N P Restifo, J C Walsh, et al.
The Journal of Experimental Medicine
|
June 13, 1998
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
A J Adler, D W Marsh, G S Yochum, et al.
International Journal of Oncology
|
November 18, 2000
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity
G L David-Beabes, M J Overman, J A Petrofski, et al.
International Journal of Oncology
|
February 10, 1998
Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines
A Nigam, R F Yacavone, M L Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancers
B A Usmani, R Shen, M Janeczko, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Der Urologe. Ausg. A
|
July 25, 2008
[CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
P J Bastian, J Ellinger, A von Rücker, et al.
The Journal of Investigative Dermatology
|
July 1, 1983
Keratin classes: molecular markers for different types of epithelial differentiation
T T Sun, R Eichner, W G Nelson, et al.
The Prostate
|
September 11, 2001
GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue
J K Parsons, C P Nelson, W R Gage, et al.
Andrology
|
October 2, 2014
Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men
W Wulaningsih, M Van Hemelrijck, K Michaelsson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1997
Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation
T L DeWeese, J C Walsh, L E Dillehay, et al.
Journal of the National Cancer Institute
|
February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancer
M G Sanda, N P Restifo, J C Walsh, et al.
The Journal of Experimental Medicine
|
June 13, 1998
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
A J Adler, D W Marsh, G S Yochum, et al.
International Journal of Oncology
|
November 18, 2000
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity
G L David-Beabes, M J Overman, J A Petrofski, et al.
International Journal of Oncology
|
February 10, 1998
Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines
A Nigam, R F Yacavone, M L Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2000
Methylation of the neutral endopeptidase gene promoter in human prostate cancers
B A Usmani, R Shen, M Janeczko, et al.
Page
of 8